T MART 20MG TABLET is used to manage essential hypertension. It contains Telmisartan which belongs to the group of medicines called Angiotensin II receptor antagonists. It is also used to reduce the risk of cardiovascular events such as heart attack or stroke in adults who are known to have a reduced or blocked blood supply to the heart or legs and had a stroke or with a high risk of diabetes. T MART 20MG TABLET makes blood vessels to relax and thus lowers the blood pressure by blocking the effects of Angiotensin II (substance produced in your body which causes narrowing of blood vessels).
Your doctor may check the kidney function test, blood pressure and the amount of electrolytes (Ex. potassium) in body prior to the management or at regular intervals during management with this medicine. T MART 20MG TABLET is not recommended for use in patients having severe liver problems such as cholestasis or biliary obstruction (flow of bile from liver stops or slows). T MART 20MG TABLET should be used with caution in patients having diabetes, kidney disease, heart problems and raised aldosterone levels.
T MART 20MG TABLET is not recommended for use in early pregnancy and must not be taken by women who are pregnant for more than 3 months and it is not recommended for use in breastfeeding women. T MART 20MG TABLET is not recommended for use in children and adolescents (up to the age of 18 years) and it should be used with caution in elderly patients (aged 65 years and above). The most common side effect of taking T MART 20MG TABLET is low blood pressure. Consult your doctor if the side effects worsen or persists for a longer period.
It is used to:
T MART 20MG TABLET makes blood vessels to relax and thus lowers the blood pressure by blocking the effects of Angiotensin II (substance produced in your body which causes narrowing of blood vessels).
Stop taking T MART 20MG TABLET and contact your doctor immediately if you experience any of the following side effects:
T MART 20MG TABLET is not recommended in early pregnancy and must not be taken when more than 3 months pregnant, as it may cause serious harm to the baby if used after 3 months of pregnancy.
T MART 20MG TABLET is not recommended for use in breastfeeding women. Your doctor may choose another management especially if you want to breast-feed when your baby is new-born or born prematurely.
Do not drive or operate any machines if you feel dizzy or tired after taking T MART 20MG TABLET.
Avoid consumption of alcohol as it may increase the risk of low blood pressure.
T MART 20MG TABLET should be taken with caution in patients with kidney disease, kidney artery stenosis (narrowing of blood vessels to one or both the kidneys) and with a history of kidney transplant.
T MART 20MG TABLET is not recommended for use in patients with severe liver problems such as cholestasis or biliary obstruction (flow of bile from liver stops or slows). T MART 20MG TABLET should be used with caution in patients with liver diseases.
Do not take T MART 20MG TABLET if you are allergic to Telmisartan or any other ingredients of this medicine.
T MART 20MG TABLET should be taken with caution in patients having heart trouble or low blood pressure (due to dehydration problems, low-salt intake, diarrhoea or vomiting).
T MART 20MG TABLET is not recommended for use in children and adolescents (under 18 years of age).
T MART 20MG TABLET should be used with caution in elderly patients (aged 65 years and above).
Before taking T MART 20MG TABLET, inform your doctor if you have:
A. Drug-Drug interactions:
Before taking T MART 20MG TABLET, inform your doctor if you are taking any of the following medicines:
Overdosage:
If you or anyone else accidentally takes too much of T MART 20MG TABLET, consult your doctor immediately or visit the nearby hospital. The most common symptoms of overdose are low blood pressure, fast or slow heartbeat, dizziness, elevated levels of creatinine and sudden kidney failure.
Drug | : | Telmisartan |
Pharmacological Category | : | Angiotensin receptor blockers |
Therapeutic Indication | : | Essential hypertension, management of heart attack and stroke |
Dosage Forms | : | Tablet |
A: T MART 20MG TABLET (telmisartan) is primarily used to manage high blood pressure (hypertension). It helps reduce the risk of heart attack, stroke, and kidney problems caused by long-term high blood pressure.
A: Yes, T MART 20MG TABLET is generally beneficial for kidneys, particularly in patients with hypertension and diabetes. By lowering blood pressure, it reduces kidney strain. However, in some cases, this medicine may cause a slight increase in creatinine levels or affect kidney function, especially in individuals with pre-existing kidney disease. Regular monitoring of kidney function is advised during treatment.
A: T MART 20MG TABLET is usually prescribed once daily. However, in cases of severe hypertension, your doctor might increase the dose to 80 mg daily or divide the dose (e.g., 40 mg twice daily). Do not adjust the dose without consulting your doctor.
A: T MART 20MG TABLET can be taken in the morning or night, depending on your doctor’s recommendation. However, taking it at the same time daily ensures consistent blood pressure control. Some studies suggest that taking blood pressure medication at night may provide better cardiovascular protection.
A: The blood pressure reduction depends on factors like the individual’s baseline BP, dose, and responsiveness to the medication. On average, this medicine can reduce Systolic BP 10-20 mmHg and diastolic BP is reduced by 5-10 mmHg. The full effect of T MART 20MG TABLET is seen after 4-6 weeks of consistent use.
A: The best time is usually once daily, at the same time every day, either morning or evening. Taking it after a meal can reduce the chance of an upset stomach.
A: T MART 20MG TABLET can cause a mild increase in serum creatinine levels in some patients. This is usually not harmful and occurs because the medication reduces the filtration pressure in the kidneys. However, a significant or persistent increase may indicate kidney problems and requires medical attention.
A: Following of the foods should be avoided while taking this medicine,
Potassium-rich foods (e.g., bananas, oranges, spinach, potatoes): Telma can raise potassium levels, and excessive potassium intake may lead to hyperkalemia (high potassium levels), Salt substitutes containing potassium and High-sodium foods: These can counteract the blood pressure-lowering effects. A low-sodium, balanced diet is recommended.
A: Telmisartan is the generic name of the drug, while T MART 20MG TABLET is a brand name manufactured by Glenmark Pharmaceuticals. Both refer to the same medication but may differ in price or additional inactive ingredients.
A: No, telmisartan does not raise cholesterol. In fact, some studies suggest that it may have a mild lipid-lowering effect by reducing triglycerides and improving HDL (good cholesterol).
A: Generally, hypertension is caused due to unhealthy lifestyle habits like high salt intake, poor diet, and excess alcohol, lack of physical activity, smoking or tobacco use, Chronic conditions like kidney disease, diabetes, or sleep apnea that can increase blood pressure or hormonal imbalances (e.g., due to thyroid disorders or adrenal gland issues), genetic and age-related factors like family history of hypertension increases risk or aging that causes stiffening of blood vessels, leading to higher blood pressure. A combination of lifestyle changes and medications like T MART 20MG TABLET is often required to manage hypertension effectively.
1. KD. Tripathi. Drugs Affecting Renin Angiotensin System. Essentials of medical pharmacology. Eighth edition. 2019. Page – 535-538.
2. Philippe Gosse. A Review of Telmisartan in the Treatment of Hypertension: Blood Pressure Control in the Early Morning Hours. NIH National Library of Medicine, National center for biotechnology information. PubMed Central. September 2006. [Accessed on 7th May 2022] click here
3. A Prem Kumar, Anirudra Ghorai, Vasudev Kriplani, Rabindra Kumar Dash, J Aravinda, Paramesh Shamanna, TK Sabeer, Abdul Hannan, and Santosh Revankar. Clinical data analysis of telmisartan for hypertension management in Indian population. NIH National Library of Medicine, National center for biotechnology information. PubMed Central June 2021. [Accessed on 7th May 2022] click here
4. Accord Healthcare Ireland Limited. Health Products Regulatory Authority (HPRA). [Revised in July 2021] [Accessed on 7th May 2022] click here
5. Hetero Labs Limited. U.S. Food & Drug Administration. [Revised in August 2015] [Accessed 7th May 2022] click here
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.